Matching articles for "Page 32"
Correction: Ferumoxytol (Feraheme)
In the Medical Letter article on Ferumoxytol (Feraheme) - A New Parenteral Iron Formulation (2010; 52:23) , the last sentence of the Dosage, Administration and Cost paragraph should have listed the cost of 1…
Med Lett Drugs Ther. 2010 Apr 19; 52(1336):32
In the Medical Letter article on Ferumoxytol (Feraheme) - A New Parenteral Iron Formulation (2010; 52:23) , the last sentence of the Dosage, Administration and Cost paragraph should have listed the cost of 1 gram of sodium ferric gluconate (Ferrlecit) as about $600.
Correction: Vancomycin Dosing and Monitoring
(Med Lett Drugs Ther 2009; 51:25) In the paragraph on dosing, the second-to-last sentence should have said that the new recommendations suggest considering use of an alternative antibiotic when the MIC for the…
Med Lett Drugs Ther. 2009 Apr 20; 51(1310):32
(Med Lett Drugs Ther 2009; 51:25) In the paragraph on dosing, the second-to-last sentence should have said that the new recommendations suggest considering use of an alternative antibiotic when the MIC for the infecting organism is ≥2 mg/L, not >2 mg/L .
In Brief: Genetic Test for Carbamazepine-Induced Stevens-Johnson Syndrome
Genetic Test for Carbamazepine-Induced Stevens-Johnson Syndrome Carbamazepine ( Tegretol, Carbatrol, Equetro , and others), which is now used to treat not only epilepsy but also trigeminal neuralgia and manic…
Med Lett Drugs Ther. 2008 Apr 21; 50(1284):29
Genetic Test for Carbamazepine-Induced Stevens-Johnson Syndrome Carbamazepine ( Tegretol, Carbatrol, Equetro , and others), which is now used to treat not only epilepsy but also trigeminal neuralgia and manic episodes in patients with bipolar disorder, 1 is a known cause of Stevens-Johnson syndrome (SJS). The incidence of carbamazepine-induced SJS in countries with mainly white populations is 1 to 6 per 10,000 new users of the drug, but Asian patients have a 10-fold higher incidence of this reaction. An association has been found between the human leukocyte antigen (HLA)-B*1502 allele and carbamazepine-induced SJS in a Chinese population. 2 This allele occurs almost exclusively in Asians. 3,4 The FDA is now recommending that Asian patients be tested for genetic susceptibility to carbamazepine-induced SJS before starting the drug. The genetic test should be available in most clinical chemistry labs. 1. Extended-release carbamazepine (Equetro) for bipolar disorder. Med Lett Drugs Ther 2005; 47:27. 2. WH Chung et al. Medical genetics: a marker for Stevens- Johnson syndrome. Nature 2004; 428:486. 3. C Lonjou et al. A marker for Stevens-Johnson syndrome. . . : ethnicity matters. Pharmacogenomics J 2006; 6:265. 4. A Alfirevic et al. HLA-B locus in Caucasian patients with carbamazepine hypersensitivity. Pharmacogenomics 2006; 7:813. Download U.S. English
